***Background.*** *Acinetobacter baumannii* has emerged as an important multidrug-resistant(MDR) healthcare-associated pathogen. Meningitis caused by these MDR pathogen is a real challenge to treat in critical care units.

***Methods.*** A 52 years old lady admitted in ITU following road traffic accident with fracture of paranasal sinuses,CSF rhiorrhea and altered sensorium. She was intubated and mechanically ventilated. He was otherwise stable but On 6th day there was few febrile spike.TLC was 22800(N90%), increased ET secretion, X-ray chest showed right lower opacity. Considering a case of ventilator associated pneumonia(VAP) emperical antibiotic started (inj Meropenem \@1gm iv tds) after sending ET suction for gram stain and culture.

***Results.*** Gram stain: Plenty pus cells, Gram negative coccobacilli, likely *Acinetobacter sp*-fair number. Considering Acinetobacter VAP inj colistin added with the existing regime @ 9 MU loading then 3 MU tds. Next day C/S report: *Acinetobacter baumannii* sensitive to colistin (MIC\<0.5) but resistant to meropenem (MIC\>16).Antibiotic combination therapy continued and patient became afebrile after 48 hours.

On 11th day patient again developed febrile spikes with drowsiness and neck rigidity. Lumbar puncture was done, CSF cloudy, Cell count-460(92% neutrophils), protein 78mg/dl, sugar 31mg/dl, all of which suggestive of bacterial meningitis. Gram stain: few gram negative coccobacilli. Considering a case of Acinetobacter meningitis, intrathecal colistin started @ 10mg/day, along with iv colistin and inj meropenem stopped. Culture grew same *Acinetobacter sp* with same antibiotic sensitivity. Treatment continued and within next couple of days patient became afebrile again, ventilator weaned off and extubated on day 17. The treatment continued for a period of two weeks with intermitten screening culture of CSF, until it became microbiologically negative. The period was otherwise uneventful except one episode of UTI caused by Proteus mirabilis which needed oral antibiotic therapy with levofloxacin. She was discharged on 27th day.

***Conclusion.*** Patients with CNS infection by MDR Acinetobacter isolates susceptible to colistin may benefit from adjunct intrathecal colistin therapy, along with IV colistin as colistin can not achieve adequate CNS penetration after iv administration.

***Disclosures.*** **All authors:** No reported disclosures.

[^1]: **Session:** 48. Treatment of Antimicrobial Resistant Infections

[^2]: Thursday, October 9, 2014: 12:30 PM
